Therefore, we focused on the role of TM4SF1 in pancreatic adenocarcinoma by observing the effects of silencing this gene on the chemotherapeutic agent in vitro and in vivo. The gene discussed is TM4SF1; the disease is pancreatic adenocarcinoma.